Brentuximab vedotin - CAS 914088-09-8
Category: ADCs
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
COA:
Inquire
Tag:
ADCs Cytotoxin with Linkers
Description:
Brentuximab vedotin is an antibody-drug conjungate (ADC) used for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin acts through targeting tumor cells with CD30 antigen expressed in.
Brife Description:
ADC, Hodgkin lymphoma (HL), anaplastic large cell lymphoma (ALCL)
Synonyms:
SGN-35; previously cAC10-vcMMAE
MSDS:
Inquire
Application:
the treatment of Hodgkin lymphoma and ALCL
Current Developer:
Seattle Genetics; Takeda Pharmaceutical
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related ADCs Cytotoxin with Linkers Products


DM4-SPDP

DM4 with a reactive linker SPDP, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site.

CAS 863971-19-1 Mc-MMAF

Mc-MMAF
(CAS: 863971-19-1)

Mc-MMAF is a protective group-conjugated MMAF, MMAF is an antitubulin agent that inhibit cell division by blocking the polymerization of tubulin and it has lowe...

CAS 863971-24-8 Mc-MMAE

Mc-MMAE
(CAS: 863971-24-8)

Mc-MMAE is a protective group conjugated MMAE, MMAE inhibits tubulin polymerization so that it inhibits cell division.

sulfo-SPDB-DM4

DM4 with a reactive linker sulfo-SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding...

CAS 1401963-17-4 Vc-MMAD

Vc-MMAD
(CAS: 1401963-17-4)

Vc-MMAD consists the ADCs linker(Val-Cit) and potent tubulin inhibitor (MMAD), Vc-MMAD is an antibody drug conjugate.

CAS 151038-96-9 DOXO-EMCH

DOXO-EMCH
(CAS: 151038-96-9)

INNO-206 is an albumin-binding prodrug of doxorubicin, which is released from albumin under acidic conditions.

CAS 138148-68-2 DM1-SMe

DM1-SMe
(CAS: 138148-68-2)

DM1-SMe is a potent maytansinoid microtubular inhibitor and an unconjugated DM1 as a mixed disulfide with thiomethane to cap its sulfhydryl group. DM1-SMe can b...

CAS 1342820-51-2 MC-Val-Ala-PBD

MC-Val-Ala-PBD
(CAS: 1342820-51-2)

MC-Val-Ala-PBD is a protective group conjugated PBD, PBD bind in the minor groove of DNA.

CAS 796073-68-2 DM4-SMe

DM4-SMe
(CAS: 796073-68-2)

DM4-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). .

CAS 796073-70-6 DM3-SMe

DM3-SMe
(CAS: 796073-70-6)

DM3-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). .

CAS 1415329-13-3 Vat-Cit-PAB-MMAD

Vat-Cit-PAB-MMAD
(CAS: 1415329-13-3)

Vat-Cit-PAB-MMAD is a protective group conjugated MMAD, MMAD is a toxin payload in antibody drug conjugate.

BA-3011

BA-3011 is a novel conditionally active biologic AXL-targeted antibody-drug conjugate used to treat solid tumor. The CAB technology is aimed to improve the sele...

CAS 1401963-15-2 Mc-MMAD

Mc-MMAD
(CAS: 1401963-15-2)

Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate; Mc-MMAD is a protective group (maleimidocaproyl) -con...

Fmoc-VC-PAB-MMAE
(CAS: 1350456-56-2)

Fmoc-Val-Cit-PAB-MMAE is an antibody drug conjugate contained Fmoc-Val-Cit-PAB and MMAE and probably have antineoplastic activity.

CAS 1361644-26-9 INNO-206

INNO-206
(CAS: 1361644-26-9)

INNO-206 (Aldoxorubicin) is the 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic acti...

CAS 1626359-62-3 DM4-SPDB

DM4-SPDB
(CAS: 1626359-62-3)

DM4 with a reactive linker SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site.

CAS 1018448-65-1 Trastuzumab emtansine

Trastuzumab emtansine
(CAS: 1018448-65-1)

Trastuzumab emtansine is an antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trast...

CAS 1228105-51-8 DM1-SMCC

DM1-SMCC
(CAS: 1228105-51-8)

DM1 with a reactive linker SMCC, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR.

CAS 646502-53-6 MC-Val-Cit-PAB-MMAE

MC-Val-Cit-PAB-MMAE
(CAS: 646502-53-6)

MC-Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate.

Val-Cit-PAB-MMAE
(CAS: 644981-35-1)

Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate.

Quick Inquiry

Verification code

Featured Items